| Literature DB >> 18655752 |
Sandrin C Bergheanu1, Theo Reijmers, Aeilko H Zwinderman, Ivana Bobeldijk, Raymond Ramaker, An-Ho Liem, Jan van der Greef, Thomas Hankemeier, J Wouter Jukema.
Abstract
OBJECTIVE: Lipid profiling (lipidomics) may be useful in revealing detailed information with regard to the effects on lipid metabolism, the cardiovascular risk and to differentiate between therapies. The aims of the present study were to: (1) analyze in depth the lipid changes induced by rosuvastatin and atorvastatin at different dosages; (2) compare differences between the two drugs with respect to the lipid profile change; (3) relate the findings with meaningful pathological mechanisms of coronary artery disease. RESEARCH DESIGN AND METHODS: Liquid chromatography-mass spectrometry was applied to obtain the metabolite profiles of plasma samples taken from a prospectively defined subset (n=80) of participants in the RADAR study where a randomly assigned treatment with rosuvastatin or atorvastatin in increasing dosages was administered during an 18-week period.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18655752 DOI: 10.1185/03007990802321709
Source DB: PubMed Journal: Curr Med Res Opin ISSN: 0300-7995 Impact factor: 2.580